Fetal and maternal microchimerism: implications for prenatal diagnosis, fetal tolerance and autoimmune disease

References

• Adams KM, Nelson JL. Microchimerism: an investigative frontier in autoimmunity and transplantation. JAMA291(9), 1127–1131 (2004).
   PubMed Web of Science ®Google Scholar
• Dennis Lo YM, Chiu RW. Prenatal diagnosis: progress through plasma nucleic acids. Nat. Rev. Genet.8(1), 71–77 (2007).
   PubMed Web of Science ®Google Scholar
• Adams KM, Yan Z, Stevens AM, Nelson JL. The Changing Maternal “Self” Hypothesis: a mechanism for maternal tolerance of the fetus. Placenta DOI: 10.1016/j.placenta.2006.07.003 (2006) (Epub ahead of print).
   Google Scholar
• Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc. Natl Acad. Sci. USA93(2), 705–708 (1996).
   PubMed Web of Science ®Google Scholar
• Maloney S, Smith A, Furst DE et al. Microchimerism of maternal origin persists into adult life. J. Clin. Invest.104(1), 41–47 (1999).
   PubMed Web of Science ®Google Scholar
• Lo YM, Tein MS, Lau TK et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am. J. Hum. Genet.62(4), 768–775 (1998).
   PubMed Web of Science ®Google Scholar
• Lo YM, Zhang J, Leung TN et al. Rapid clearance of fetal DNA from maternal plasma. Am. J. Hum. Genet.64(1), 218–224 (1999).
   PubMed Web of Science ®Google Scholar
• Faas BH, Beuling EA, Christiaens GC, von dem Borne AE, van der Schoot CE. Detection of fetal RHD-specific sequences in maternal plasma. Lancet352(9135), 1196 (1998).
   PubMed Web of Science ®Google Scholar
• Lo YM, Hjelm NM, Fidler C et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N. Engl. J. Med.339(24), 1734–1738 (1998).
   PubMed Web of Science ®Google Scholar
• Bianchi DW, Avent ND, Costa JM, van der Schoot CE. Noninvasive prenatal diagnosis of fetal rhesus D: ready for prime(r) time. Obstet. Gynecol.106(4), 841–844 (2005).
   PubMedGoogle Scholar
• Finning K, Martin P, Daniels G. A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma. Ann. NY Acad. Sci.1022, 119–123 (2004).
   PubMed Web of Science ®Google Scholar
• Moise KJ. Fetal RhD typing with free DNA in maternal plasma. Am. J. Obstet. Gynecol.192(3), 663–665 (2005).
   PubMedGoogle Scholar
• Zhou L, Thorson JA, Nugent C et al. Noninvasive prenatal RHD genotyping by real-time polymerase chain reaction using plasma from D-negative pregnant women. Am. J. Obstet. Gynecol.193(6), 1966–1971 (2005).
   PubMed Web of Science ®Google Scholar
• Grootkerk-Tax MG, Soussan AA, de Haas M, Maaskant-van Wijk PA, van der Schoot CE. Evaluation of prenatal RHD typing strategies on cell-free fetal DNA from maternal plasma. Transfusion46(12), 2142–2148 (2006).
   PubMed Web of Science ®Google Scholar
• Saito H, Sekizawa A, Morimoto T, Suzuki M, Yanaihara T. Prenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet356(9236), 1170 (2000).
   PubMed Web of Science ®Google Scholar
• Amicucci P, Gennarelli M, Novelli G, Dallapiccola B. Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma. Clin. Chem.46(2), 301–302 (2000).
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gonzalez MC, Garcia-Hoyos M, Trujillo MJ et al. Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma. Prenat. Diagn.22(10), 946–948 (2002).
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gonzalez MC, Trujillo MJ, Rodriguez de Alba M, Ramos C. Early Huntington disease prenatal diagnosis by maternal semiquantitative fluorescent-PCR. Neurology60(7), 1214–1215 (2003).
   PubMed Web of Science ®Google Scholar
• Chiu RW, Lau TK, Cheung PT et al. Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study. Clin. Chem.48(5), 778–780 (2002).
   PubMed Web of Science ®Google Scholar
• Chiu RW, Lau TK, Leung TN et al. Prenatal exclusion of β thalassaemia major by examination of maternal plasma. Lancet360(9338), 998–1000 (2002).
   PubMed Web of Science ®Google Scholar
• Li Y, Di Naro E, Vitucci A et al. Detection of paternally inherited fetal point mutations for β-thalassemia using size-fractionated cell-free DNA in maternal plasma. JAMA293(7), 843–849 (2005).
   PubMed Web of Science ®Google Scholar
• Ding C, Chiu RW, Lau TK et al. MS analysis of single-nucleotide differences in circulating nucleic acids: application to noninvasive prenatal diagnosis. Proc. Natl Acad. Sci. USA101(29), 10762–10767 (2004).
   PubMed Web of Science ®Google Scholar
• Lo YM, Leung TN, Tein MS et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin. Chem.45(2), 184–188 (1999).
   PubMed Web of Science ®Google Scholar
• Leung TN, Zhang J, Lau TK, Hjelm NM, Lo YM. Maternal plasma fetal DNA as a marker for preterm labour. Lancet352(9144), 1904–1905 (1998).
   PubMed Web of Science ®Google Scholar
• Zhong XY, Burk MR, Troeger C et al. Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses. Prenat. Diagn.20(10), 795–798 (2000).
   PubMed Web of Science ®Google Scholar
• Levine RJ, Qian C, Leshane ES et al. Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am. J. Obstet. Gynecol.190(3), 707–713 (2004).
   PubMed Web of Science ®Google Scholar
• Wataganara T, LeShane ES, Farina A et al. Maternal serum cell-free fetal DNA levels are increased in cases of trisomy 13 but not trisomy 18. Hum. Genet.112(2), 204–208 (2003).
   PubMed Web of Science ®Google Scholar
• Farina A, LeShane ES, Lambert-Messerlian GM et al. Evaluation of cell-free fetal DNA as a second-trimester maternal serum marker of Down syndrome pregnancy. Clin. Chem.49(2), 239–242 (2003).
   PubMedGoogle Scholar
• Ng EK, Tsui NB, Lau TK et al. mRNA of placental origin is readily detectable in maternal plasma. Proc. Natl Acad. Sci. USA100(8), 4748–4753 (2003).
   PubMed Web of Science ®Google Scholar
• Lo YM, Tsui NB, Chiu RW et al. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat. Med.13(2), 218–223 (2007).
   PubMed Web of Science ®Google Scholar
• Poon LL, Leung TN, Lau TK, Chow KC, Lo YM. Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma. Clin. Chem.48(1), 35–41 (2002).
   PubMed Web of Science ®Google Scholar
• Chim SS, Tong YK, Chiu RW et al. Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc. Natl Acad. Sci. USA102(41), 14753–14758 (2005).
   PubMed Web of Science ®Google Scholar
• Flori E, Doray B, Gautier E et al. Circulating cell-free fetal DNA in maternal serum appears to originate from cyto- and syncytio-trophoblastic cells. Case report. Hum. Reprod.19(3), 723–724 (2004).
   PubMed Web of Science ®Google Scholar
• Huppertz B, Kadyrov M, Kingdom JC. Apoptosis and its role in the trophoblast. Am. J. Obstet. Gynecol.195(1), 29–39 (2006).
   PubMed Web of Science ®Google Scholar
• Ranella A, Vassiliadis S, Mastora C et al. Constitutive intracellular expression of human leukocyte antigen (HLA)-DO and HLA-DR but not HLA-DM in trophoblast cells. Hum. Immunol.66(1), 43–55 (2005).
   PubMedGoogle Scholar
• Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu. Rev. Immunol.21, 685–711 (2003).
   PubMed Web of Science ®Google Scholar
• Steinbrink K, Jonuleit H, Muller G et al. Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Blood93(5), 1634–1642 (1999).
   PubMed Web of Science ®Google Scholar
• Hench PS. The ameliorating effect of pregnancy on chronic atrophic infectious rheumatoid arthritis, fibrositis, and intermittent hydroarthrosis. Mayo Clin. Proc.13, 161–167 (1938).
   Google Scholar
• Nelson JL, Ostensen M. Pregnancy and rheumatoid arthritis. Rheum. Dis. Clin. North Am.23(1), 195–212 (1997).
   PubMed Web of Science ®Google Scholar
• Winchester R, Dwyer E, Rose S. The genetic basis of rheumatoid arthritis. The shared epitope hypothesis. Rheum. Dis. Clin. North Am.18(4), 761–783 (1992).
   PubMed Web of Science ®Google Scholar
• Engelhard VH. Structure of peptides associated with class I and class II MHC molecules. Annu. Rev. Immunol.12, 181–207 (1994).
   PubMed Web of Science ®Google Scholar
• Yan Z, Lambert NC, Ostensen M et al. Prospective study of fetal DNA in serum and disease activity during pregnancy in women with inflammatory arthritis. Arthritis Rheum.54(7), 2069–2073 (2006).
   PubMedGoogle Scholar
• Nelson JL. Maternal-fetal immunology and autoimmune disease: is some autoimmune disease auto-alloimmune or allo-autoimmune? Arthritis Rheum.39(2), 191–194 (1996).
   PubMed Web of Science ®Google Scholar
• Rouquette-Gally AM, Boyeldieu D, Gluckman E, Abuaf N, Combrisson A. Autoimmunity in 28 patients after allogeneic bone marrow transplantation: comparison with Sjogren syndrome and scleroderma. Br. J. Haematol.66(1), 45–47 (1987).
   PubMedGoogle Scholar
• Scaletti C, Vultaggio A, Bonifacio S et al. Th2-oriented profile of male offspring T cells present in women with systemic sclerosis and reactive with maternal major histocompatibility complex antigens. Arthritis Rheum.46(2), 445–450 (2002).
   PubMedGoogle Scholar
• Lambert NC, Lo YM, Erickson TD et al. Male microchimerism in healthy women and women with scleroderma: cells or circulating DNA? A quantitative answer. Blood100(8), 2845–2851 (2002).
   PubMed Web of Science ®Google Scholar
• Artlett CM, Cox LA, Ramos RC et al. Increased microchimeric CD4+ T lymphocytes in peripheral blood from women with systemic sclerosis. Clin. Immunol.103(3 Pt 1), 303–308 (2002).
   PubMed Web of Science ®Google Scholar
• Nelson JL, Furst DE, Maloney S et al. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet351(9102), 559–562 (1998).
   PubMed Web of Science ®Google Scholar
• Davies TF. The thyroid immunology of the postpartum period. Thyroid9(7), 675–684 (1999).
   PubMed Web of Science ®Google Scholar
• Klintschar M, Schwaiger P, Mannweiler S, Regauer S, Kleiber M. Evidence of fetal microchimerism in Hashimoto’s thyroiditis. J. Clin. Endocrinol. Metab.86(6), 2494–2498 (2001).
   PubMed Web of Science ®Google Scholar
• Ando T, Imaizumi M, Graves PN, Unger P, Davies TF. Intrathyroidal fetal microchimerism in Graves’ disease. J. Clin. Endocrinol. Metab.87(7), 3315–3320 (2002).
   PubMed Web of Science ®Google Scholar
• Klintschar M, Immel UD, Kehlen A et al. Fetal microchimerism in Hashimoto’s thyroiditis: a quantitative approach. Eur. J. Endocrinol.154(2), 237–241 (2006).
   PubMedGoogle Scholar
• Srivatsa B, Srivatsa S, Johnson KL et al. Microchimerism of presumed fetal origin in thyroid specimens from women: a case–control study. Lancet358(9298), 2034–2038 (2001).
   PubMed Web of Science ®Google Scholar
• Walsh JP, Bremner AP, Bulsara MK et al. Parity and the risk of autoimmune thyroid disease: a community-based study. J. Clin. Endocrinol. Metab.90(9), 5309–5312 (2005).
   PubMedGoogle Scholar
• Hovinga IC, Koopmans M, Baelde HJ et al. Chimerism occurs twice as often in lupus nephritis as in normal kidneys. Arthritis Rheum.54(9), 2944–2950 (2006).
   PubMedGoogle Scholar
• Abbud Filho M, Pavarino-Bertelli EC, Alvarenga MP et al. Systemic lupus erythematosus and microchimerism in autoimmunity. Transplant Proc.34(7), 2951–2952 (2002).
   PubMedGoogle Scholar
• Turner JH, Wald N, Quinlivan WL. Cytogenetic evidence concerning possible transplacental transfer of leukocytes in pregnant women. Am. J. Obstet. Gynecol.95(6), 831–833 (1966).
   PubMedGoogle Scholar
• El-Alfi OS, Hathout H. Maternofetal transfusion: immunologic and cytogenetic evidence. Am. J. Obstet. Gynecol.103(4), 599–600 (1969).
   PubMedGoogle Scholar
• Duhring JL, Smith K, Greene JW Jr, Rochlin DB, Blakemore WS. Placental transfer of maternal erythrocytes into the fetal circulation. Surg. Forum10, 720–722 (1960).
   PubMedGoogle Scholar
• Desai RG, Creger WP. Maternofetal passage of leukocytes and platelets in man. Blood21, 665–673 (1963).
   PubMed Web of Science ®Google Scholar
• Srivatsa B, Srivatsa S, Johnson KL, Bianchi DW. Maternal cell microchimerism in newborn tissues. J. Pediatr.142(1), 31–35 (2003).
   PubMed Web of Science ®Google Scholar
• Stevens AM Hermes HH, Rutledge R, Buyon J, Nelson JL. Maternal microchimerism has myocardial tissue-specific phenotype in neonatal lupus congenital heart block. Lancet362(9396), 1617–1623 (2003).
   PubMed Web of Science ®Google Scholar
• Lo YM, Lo ES, Watson N et al. Two-way cell traffic between mother and fetus: biologic and clinical implications. Blood88(11), 4390–4395 (1996).
   PubMed Web of Science ®Google Scholar
• Loubiere LS, Lambert NC, Flinn LJ et al. Maternal microchimerism in healthy adults in lymphocytes, monocyte/macrophages and NK cells. Lab. Invest.86(11), 1185–1192 (2006).
   PubMed Web of Science ®Google Scholar
• Anderson DJ, Gage FH, Weissman IL. Can stem cells cross lineage boundaries? Nat. Med.7(4), 393–395 (2001).
   PubMed Web of Science ®Google Scholar
• Cogle CR, Yachnis AT, Laywell ED et al. Bone marrow transdifferentiation in brain after transplantation: a retrospective study. Lancet363, 1432–1437 (2004).
   PubMed Web of Science ®Google Scholar
• Wagers AJ, Weissman IL. Plasticity of adult stem cells. Cell116, 639–648 (2004).
   PubMed Web of Science ®Google Scholar
• Fujimiya M, Kojima H, Ichinose M et al. Fusion of proinsulin-producing bone marrow-derived cells with hepatocytes in diabetes. PNAS104, 4030–4035 (2007).
   PubMed Web of Science ®Google Scholar
• Nelson JL, Gillespie KM, Lambert NC et al. Maternal microchimerism in peripheral blood in tType 1 diabetes and pancreatic islet β cell microchimerism. Proc. Natl Acad. Sci. USA104(5), 1637–1642 (2007).
   PubMed Web of Science ®Google Scholar
• Reed AM Picomell YJ, Harwood A, Kredich DW. Chimerism in children with juvenile dermatomyositis. Lancet356, 2156–2157 (2000).
   PubMed Web of Science ®Google Scholar
• Artlett CM Ramos R, Jiminez SA, Patterson K, Miller FW, Rider LG. Detection of microchimeric cells of maternal origin in the periphery and tissues of patients with juvenile idiopathic inflammatory myopathies. Lancet356, 2155–2156 (2000).
   PubMedGoogle Scholar
• Artlett CM, Miller FW, Rider LG. Persistent maternally derived peripheral microchimerism is associated with the juvenile idiopathic inflammatory myopathies. Rheumatology (Oxf.)40(11), 1279–1284 (2001).
   PubMed Web of Science ®Google Scholar
• Khosrotehrani K, Guegan S, Fraitag S et al. Presence of chimeric maternally derived keratinocytes in cutaneous inflammatory diseases of children: the example of pityriasis lichenoides. J. Invest. Dermatol.126(2), 345–348 (2006).
   PubMedGoogle Scholar
• Lambert NC, Erickson TD, Yan Z et al. Quantification of maternal microchimerism by HLA-specific real-time PCR. Studies of healthy women and women with scleroderma. Arthritis Rheum.50(3), 906–914 (2004).
   PubMed Web of Science ®Google Scholar
• Lambert NC, Distler O, Muller-Ladner U, Tylee TS, Furst DE, Nelson JL. HLA-DQA1*0501 is associated with diffuse systemic sclerosis in Caucasian men. Arthritis Rheum.43(9), 2005–2010 (2000).
   PubMed Web of Science ®Google Scholar
• Ichinohe T, Teshima T, Matsuoka K, Maruya E, Saji H. Fetal–maternal microchimerism: impact on hematopoietic stem cell-transplantation. Curr. Opin. Immunol.17(5), 546–552 (2005).
   PubMed Web of Science ®Google Scholar
• van Rood JJ, Roelen DL, Claas FH. The effect of noninherited maternal antigens in allogeneic transplantation. Semin. Hematol.42, 104–111 (2005).
   PubMed Web of Science ®Google Scholar
• van Rood JJ, Loberiza FR Jr, Zhang MJ et al. Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling. Blood99(5), 1572–1577 (2002).
   PubMed Web of Science ®Google Scholar
• Tamaki S, Ichinohe T, Matsue K et al. Superior survival of blood and marrow stem cell recipients given maternal grafts over recipients given paternal grafts. Bone Marrow Transplant28, 375–380 (2001).
   PubMed Web of Science ®Google Scholar
• Shimazaki C, Ochiai N, Uchida R et al. Non-T-cell-depleted HLA haploidentical stem cell transplantation in advanced hematologic malignancies based on the feto-maternal microchimerism. Blood101(8), 3334–3336 (2003).
   PubMed Web of Science ®Google Scholar
• Burlingham WJ, Grailer AP, Heisey DM et al. The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors. N. Engl. J. Med.339(23), 1657–1664 (1998).
   PubMed Web of Science ®Google Scholar
• van Twuyer E, Mooijaart R, ten Berge I et al. Pretransplantation blood transfusion revisited. N. Engl. J. Med.325, 1210–1213 (1991).
   PubMed Web of Science ®Google Scholar
• Adams KM, Lambert NC, Heimfeld S et al. Male DNA in peripheral blood stem cell apheresis products of female donors. Blood102, 3845–3847 (2003).
   PubMedGoogle Scholar
• Perreault C, Roy DC, Fortin C. Immunodominant minor histocompatibility antigens: the major ones. Immunol. Today19, 69–74 (1998).
   PubMedGoogle Scholar
• Adams KM, Holmberg LA, Leisenring WM et al. Risk factors for syngeneic graft-versus-host disease after adult hematopoietic cell transplantation. Blood104(6), 1894–1897 (2004).
   PubMed Web of Science ®Google Scholar
• Flowers ME, Pepe MS, Longton G et al. Previous donor pregnancy as a risk factor for acute graft-versus-host disease in patients with aplastic anaemia treated by allogeneic marrow transplantation. Br. J. Haematol.74(4), 492–496 (1990).
   PubMed Web of Science ®Google Scholar